rhabdomyosarcoma/diarreia

O link é salvo na área de transferência

Escolha o tipo de classificação

Página 1 a partir de 30 resultados

Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

OBJECTIVE This phase II study was designed to evaluate the efficacy of irinotecan administered intravenously once every 3 weeks in pediatric patients with recurrent or refractory rhabdomyosarcoma. METHODS A total of 35 patients younger than age 20 years, with refractory or relapsed rhabdomyosarcoma

Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcoma.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND Rhabdomyosarcoma is the most frequently encountered soft tissue sarcoma in children younger than 15 years of age. METHODS The authors reviewed the early and long-term morbidity rate and clinical outcome of pelvic exenteration for genitourinary rhabdomyosarcoma (GU-RMS) in children. Of 43

Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

OBJECTIVE We report on long-term health-related problems determined from extended follow-up of 86 children and adolescents who were treated for paratesticular rhabdomyosarcoma on the Intergroup Rhabdomyosarcoma Studies I and II (IRS I-II). METHODS Patients were treated between 1972 and 1984, and

Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

OBJECTIVE To estimate the antitumor activity and toxicity of irinotecan alone and in combination with vincristine when administered as window therapy and in combination with standard chemotherapy in pediatric patients with newly diagnosed metastatic rhabdomyosarcoma. METHODS Nineteen patients

Life-Threatening Irinotecan-Induced Toxicity in an Adult Patient with Alveolar Rhabdomyosarcoma: The Role of a UGT1A1 Polymorphism.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Alveolar rhabdomyosarcoma (AR) in adult patients is an exceptional malignancy. Management of AR is based on (neo)adjuvant chemotherapy combining ifosfamide, vincristine, and actinomycin D and local curative-intent surgery/radiotherapy. In cases of relapsing AR, the combination of

Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: a report on toxicity and efficacy from a prospective pilot phase II study.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND Irinotecan is highly active against rhabdomyosarcoma (RMS), yet its tolerability and efficacy in combination with radiation is unknown. We examined local control and toxicities in RMS patients treated with radiotherapy (RT) in combination with radiosensitizing agents irinotecan +

Isolation of bovine viral diarrhea virus 1, a pestivirus from autopsied lamb specimen from Tamil Nadu, India.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

An epizootic of febrile illness among the Madras red breed of sheep had occurred in 1994 in Verrapuram, Chennai, India. The epizootic was suspected as Rift Valley fever (RVF)-like sickness based on clinical features. However, its etiological agent could neither be isolated nor implicated

Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND Outpatient oral therapy is infrequently used in pediatric low-risk febrile neutropenia (LRFN) as there is insufficient data regarding its equivalence as compared with parenteral therapy. METHODS This is a single institutional, randomized control trial in pediatric LRFN aged 2 to 15 years,

[Irinotecan plus temozolomide in refractory or relapsed pediatric solid tumors].

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND The prognosis of refractory or relapsed pediatric solid tumors is very poor, and there is no standard treatment for this condition. The combination of irinotecan and temozolomide has proved useful in adults as a second-line treatment of different solid tumors. In pediatric patients, this

Phase II study of docetaxel in advanced soft tissue sarcomas.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Because of its unusual mechanism of action, docetaxel was selected for study in advanced soft tissue sarcomas of adults as part of a search for new active antisarcoma agents. Patients at least 18 years old with measurable histologically proven advanced nonosseous sarcomas were enrolled if they had

Posterior sagittal approach with perirectal dissection for reconstructive surgery of severe urogenital anomalies.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

There are many approaches for surgery of complicated congenital and acquired urogenital anomalies in children with intact rectum. Pena advocates the mid-sagittal division of the sphincter mechanism posterior and anterior to the rectum, along with opening of the posterior and anterior rectal walls.

A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND Based on evidence of activity in preclinical and Phase I studies, the authors undertook a study of bortezomib, a reversible proteasome inhibitor, for patients with metastatic sarcomas. METHODS Two arms were opened, each using a Simon two-stage design. Arm A included patients with

Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

From 1987 to 1995, 22 children with refractory solid tumors entered a phase II study of high-dose thiotepa (HDT) (900 mg/m2) followed by stem cell transplantation (SCT) in the Pediatrics Department of the Institut Gustave Roussy. Tumor types were rhabdomyosarcoma (eight), osteosarcoma (seven),

Efficacy and safety of linezolid in immunocompromised children with cancer.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND The aim of this study was to determine the safety, tolerance and efficacy of linezolid for the treatment of infections from Gram-positive bacteria in immunocompromised children with cancer. METHODS This was a prospective non-comparative unblinded study in the Hematology/Oncology Unit over

A phase I study of irinotecan administered on a weekly schedule in pediatric patients.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND The objectives of this study were to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), pharmacokinetics, and anti-tumor effect of irinotecan in pediatric patients with recurrent or refractory malignancies. METHODS Twenty-three patients between 1 and 21 years of

Junte-se à nossa
página do facebook

Herbal & Natural Medicine

O mais completo banco de dados de ervas medicinais apoiado pela ciência

Funciona em 55 idiomas
Curas herbais apoiadas pela ciência
Reconhecimento de ervas por imagem
Mapa GPS interativo - marcar ervas no local (em breve)
Leia publicações científicas relacionadas à sua pesquisa
Pesquise ervas medicinais por seus efeitos
Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas